ESR1 and breast cancer: Similarly, in luminal ERα-positive breast cancer cell lines, AR exerts an anti-proliferative effect [11–16] while in MDA-MB-453, a model of ERα-negative apocrine disease, activated AR can induce cancer growth [17, 18].